Bathroom Reading
A newly approved anti-diarrheal agent seeks to counter side effects of HAART
by Chael Needle
Recently, the FDA approved Fulyzaq (crofelemer) 125 mg delayed-release tablets for...
Listen with Care
Natasha Travis, MD, helps shape the HIV learning curve for physicians and patients
by Chael Needle
Awarded a 2012 Minority Clinical Fellowship by the HIV Medicine...
Janssen Announces FDA Approval of SYMTUZA
The Janssen Pharmaceutical Companies of Johnson & Johnson announced on July 18, 2018 that the U.S. FDA has approved the use of SYMTUZA, the...
Borrowing Therapies
Two Anti-Cancer Drugs Are Tapped in the Fight Against HIV
by Chael Needle
New types of drugs are needed in the fight against HIV but some of...
SMYD2 & the HIV Reservoir
Shock Value
Research on SMYD2 shows potential to wake up the HIV reservoir
by Chael Needle
HIV latency—where HIV hides out in reservoirs, dormant and beyond the...
Highest HIV Viral Suppression Rate in New Ryan White Program
Highest HIV Viral Suppression Rate in New Ryan White Program
In its fifth annual publication of national client-level data from the Ryan White HIV/AIDS Program...
FDA Approves New HIV Treatments
The U.S. Food and Drug Administration (FDA) has approved pharmaceutical giant Merck’s Delstrigo and Pifeltro for the treatment of HIV-1 infection in adult patients...
Alisson Sombredero, MD
Not So Complicated
Alisson Sombredero, MD, offers to physicians compelling approaches to HIV care
by Chael Needle
Alisson Sombredero, MD, is more than two months into her...
The Road Ahead
LifeGuide
Treatment Horizons
The Road Ahead
New candidates hold promise for ARV therapy & therapeutic vaccines
by Mariel Selbovitz, MPH
The 54th Interscience Conference on Antimicrobial Agents and Chemotherapy...
Protecting the Pipeline
LifeGuide
HIV drug development faces challenges
by Jeannie Wraight and Mariel Selbovitz, MPH
Triple and now quad drugs like Gilead’s Atripla and their new compound known...
LATEST POSTS
$210M Funding Opportunity for CBOs
CDC Announces $210M Funding Opportunity for CBOs
On September 28, 2020, the Centers for Disease Control and Prevention (CDC) announced the availability in fiscal 2021...
